Vice President, Payer Strategy

Location: Remote Position Pay Range: $117,644.80 - $258,793.60 Position Summary The Vice President of Payer Strategy provides national leadership for payer contracting execution, operational infrastructure, and team management across American Oncology Network (AON). This role is accountable for translating enterprise payer strategy into disciplined, scalable execution across all markets. Serving as the primary operational leader for payer contracting, the Vice President ensures alignment between strategy, people, process, and technology. This includes oversight of Contracting-Credentialing workflows, team performance, and system utilization across AON Technology platforms. This role partners reports to Chief Strategy and Innovation Officer (CSIO). Key Performance Areas KPA 1 - National Payer Contracting Leadership & Execution Lead day-to-day execution of payer contracting across all AON markets. Ensure consistent, timely, and high-quality execution of negotiations, renewals, and onboarding activities. Establish national standards for contracting workflows, timelines, and deliverables. Drive accountability for execution performance across regions and contracting teams. Serve as escalation point for complex operational contracting issues. KPA 2 - People Leadership & Organizational Development Lead, mentor, and scale the national payer contracting team (Directors, Managers, and Analysts). Establish clear performance expectations, KPIs, and accountability structures. Build a high-functioning operating cadence including daily huddles, weekly execution reviews, and performance reporting. Develop talent pipelines and succession planning within payer strategy. Foster a culture of ownership, precision, and execution discipline. KPA 3 - Process, Workflow & Operational Infrastructure Own and optimize end-to-end contracting-credentialing workflows across all markets. Standardize processes for payer onboarding, renegotiations, and contract-credentialing lifecycle management. Ensure integrity and consistency of contracting documentation, trackers, and reporting tools. Partner with Revenue Cycle, and Operations to ensure seamless execution across functions. Identify operational gaps and implement scalable process improvements. KPA 4 - Systems, Technology & Data Enablement Drive operational adoption and optimization of: Evisort (contract lifecycle management). Turquoise Health (rate benchmarking and market intelligence). SharePoint (documentation and workflow standardization). Other tools as needed. Ensure accurate and consistent use of data and systems to support execution and reporting. Work with CSIO and analytics teams to inform future AI-enabled payer infrastructure. Enable system-driven visibility into performance, pipeline, and outcomes. KPA 5 - Strategic Execution & CSIO Partnership Operationalize enterprise payer strategy into actionable execution plans. Serve as the execution counterpart to the CSIO, ensuring strategy translates into results. Provide structured reporting and insights to support executive decision-making. Support scalability of payer strategy across new markets and practice expansions. Maintain alignment with broader organizational priorities including value-based care and market growth. Role Boundaries (Not Responsible For) Ownership of enterprise payer strategy design or innovation architecture (CSIO-led) Development of AI infrastructure or advanced analytics systems. Position Qualifications Education Bachelor’s degree required. Master’s degree (MBA, MHA, or related) preferred. Minimum Relevant Experience 10+ years of payer contracting, managed care, or healthcare strategy experience. 5+ years in leadership roles managing multi-market teams. Skills Experience in oncology or specialty physician network contracting. Deep familiarity with payer negotiation dynamics (commercial and Medicare Advantage). Experience with contracting platforms such as Evisort and benchmarking tools such as Turquoise Health. Proven ability to scale operations across multi-state provider organizations. Travel: 0-25% #LI-REMOTE